
|Articles|January 24, 2008
Heparin injection recalled as Baxter investigates
Baxter issues voluntary recall of heparin
Advertisement
Reported adverse events associated with Baxter's heparin sodium injection 1000 units/ml have prompted the company to recall certain lots of the product while it investigates the cause. The affected lots include both 10-ml and 30-ml vials. The 10-ml vials affected are from lots 107054 and 117085. The 30-ml vials affected include lots 047056, 097081, 107024, 107064, 107066, 107074, and 107111. A complete list of reported adverse events can be found at
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Embedded Pharmacists Are Vital Yet Underutilized in Diabetes Care
2
Executive Order Calls for Realignment of Childhood Vaccines
3
The Prodigious PBM Pivot: How Supply Chain Entities Will Move Forward After CAA 2026
4
Heat and Older Adults: What Pharmacists Need to Know
5





























































